Key result
The ACS-NSQIP Risk Calculator underpredicted all complications (29% predicted vs 45% observed) after total gastrectomy, but showed good discrimination for cardiac complications and death.
Why the study?
Does the ACS-NSQIP Risk Calculator accurately predict adverse outcomes in patients undergoing total gastrectomy for gastric cancer?
Cohort (n=452)
No
Does the ACS-NSQIP Risk Calculator accurately predict adverse outcomes in patients undergoing total gastrectomy for gastric cancer?
Absolute Event Rate: 29% vs 45%
The ACS-NSQIP Risk Calculator has variable performance for predicting adverse outcomes after total gastrectomy, with best accuracy for cardiac complications, renal failure, death, and discharge disposition.
May warrant cautious use of the ACS-NSQIP calculator for total gastrectomy; leaves open need for procedure-specific validation.
BACKGROUND: To encourage implementation of the American College of Surgeons (ACS) NSQIP Risk Calculator for total gastrectomy for gastric cancer, its predictive performance for this specific procedure should be validated. We assessed its discriminatory accuracy and goodness of fit for predicting 12 adverse outcomes. STUDY DESIGN: Data were collected on all patients with gastric cancer who underwent total gastrectomy with curative intent at Memorial Sloan Kettering Cancer Center between 2002 and 2017. Preoperative risk factors from the electronic medical record were manually inserted into the ACS-NSQIP Risk Calculator. Predictions for adverse outcomes were compared with observed outcomes by Brier scores, c-statistics, and Hosmer-Lemeshow p value. RESULTS: In a total of 452 patients, the predicted rate of all complications (29%) was lower than the observed rate (45%). Brier scores varied between 0.017 for death and 0.272 for any complication. C-statistics were moderate (0.7-0.8) for death and renal failure, good (0.8-0.9) for cardiac complication, and excellent (≥0.9) for discharge to nursing or rehabilitation facility. Hosmer-Lemeshow p value found poor goodness of fit for pneumonia only. CONCLUSIONS: For adverse outcomes after total gastrectomy with curative intent in gastric cancer patients, performance of the ACS-NSQIP Risk Calculator is variable. Its predictive performance is best for cardiac complications, renal failure, death, and discharge to nursing or rehabilitation facility.
No takes yet. Share an insight, caveat, or question.
Vos et al. (2020) conducted a cohort in gastric cancer (n=452). ACS-NSQIP Risk Calculator vs. observed outcomes was evaluated on all complications. The ACS-NSQIP Risk Calculator underpredicted all complications (29% predicted vs 45% observed) after total gastrectomy, but showed good discrimination for cardiac complications and death.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: